-
IntroducedApr 01, 2025
-
Passed Senate
-
Passed House
-
Signed into Law
Regards prescription drugs and medication switching
Last Action See all actions
Senate • Apr 02, 2025: Referred to committee (Financial Institutions, Insurance and Technology)
Latest Bill Text See all bill texts
Oct 21, 2025 04:00pm
Finance Hearing Room
Summary/Bill Text
Comments on SB 160
Tweets
Whip Lists
Sponsors
Votes
Actions
- Apr 02, 2025 | Senate
- Referred to committee (Financial Institutions, Insurance and Technology)
- Apr 01, 2025 | Senate
- Introduced
Bill Texts
Documents
- Analysis - As IntroducedPDF
- Testimony by Senator Beth Liston (16th District, Sponsor) -- Financial Institutions, Insurance and Technology, 1st Hearing (June 17, 2025)
- Testimony by Monica Hueckel (Ohio State Medical Association, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)
- Testimony by Stephanie Ott, MD (Ohio Association of Rheumatology, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)
- Testimony by Matthew Freado (Ohio Association of Physicians Assistants, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)
- Testimony by Lynn Schuchter, MD, FASCO & Slobodan Stanisic, MD (Association for Clinical Oncology & Ohio Hematology Oncology Society, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)
- Testimony by Gary Dougherty (American Diabetes Association, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)
- Testimony by Janet Shaw, MBA (Ohio Psychiatric Physicians Association, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)
- Testimony by Jill Hostetler (Ohio Dermatological Association, Proponent) -- Financial Institutions, Insurance and Technology, 2nd Hearing (September 30, 2025)